[vc_row][vc_column width=”1/5″]
Prof. Matthias Schwab, Germany
COUNCILLOR
Personal
* September 3, 1963
[/vc_column]
[vc_column width=”4/5″]
ACADEMIC DEGREES AND FELLOWSHIP
| 1983-1990 | Study of medicine, Friedrich-Alexander University of Erlangen-Nürnberg |
| 1991 | MD, Institute of Toxicology and Pharmacology, University Erlangen Nürnberg |
| 1992 | State Licence as medical doctor |
| 1990-1995 | Fellowship in children’s medicine, Nürnberg and University Erlangen Nürnberg |
| 1996 | Board certification Paediatrics and Adolescent Medicine |
| 1996-2000 | fellowship in Clinical Pharmacology, IKP Stuttgart |
| 2000 | Board certification: Clinical Pharmacology |
| 2003 | Habilitation and Venia Legendi (Clinical Pharmacology and Paediatric Pharmacology) Medical Faculty, Eberhard-Karls University Tuebingen |
| 2005-2006 | Visiting Professor, St. Jude Children’s Research Hospital, Department of Pharmaceutical Sciences, Memphis, Tennessee, USA |
| 2006 | Offer as Full Professor/Chair for Clin. Pharmacology, Medical University Innsbruck, Austria |
| 2007 | Full Professor/Chair of Clin. Pharmacology (W3/C4), Eberhard Karl University Tuebingen, |
| 2010 | Offer as Full Professor/Chair for Clin. Pharmacology, Karolinska University, Sweden in combination with a clinical position as Senior Physician at Karolinska University |
EMPLOYMENT
| 1990-1993 | Civilian service as house officer at the Children’s Hospital, Nuernberg, Germany |
| 1993-1995 | Senior house officer at the University Hospital of Children and Adolescents, Erlangen, Germany |
| 1995-2000 | Fellow in Clin pharmacology at the IKP, Stuttgart, Germany |
| 2001-2005 | Senior physician/Head of the Clinical Trial Unit and Drug Information Centre at IKP Stuttgart |
| 2005-2006 | Visiting Professor, St. Jude Children’s Research Hospital, Memphis, TN, USA |
| Since 2007 | Director of IKP Stuttgart & Dept. Clinical Pharmacology, University Hospital Tuebingen |
HONOURS / AWARDS / MEMBERSHIPS
| 1983-1990 | Scholarship according to the “Bayerischen Begabtenförderungsgesetz” (1983 – 1990) |
| since 1998 | Member of the Committee of Drug Safety (German Society of Child & Adolescent Medicine) |
| since 2006 | Member and Vice Chair of the Expert Group Drugs for Children and Adolescents (BfArM) |
| since 2004 | Member of the ethical committee of the Landesärztekammer Baden-Württemberg |
| 2004 | Friedrich Hartmut Dost Award |
| 2005 | Galenus von Pergamon Award |
| since 2007 | Member of the „Drug Commission of the German Medical Association (AkdÄ) |
| since 2009 | Member of the Chair of the Comprehensive Cancer Center (CCC) of the University Tübingen |
| since 2007 | Editor-in-Chief of Pharmacogenetics & Genomics |
| 2009 | Most cited pharmacologist in German-speaking countries (Laborjournal, 2009) |
| since 2010 | Section Editor for Personalized Medicine and Therapeutics of Genome Medicine |
| 2010-2013 | Expert for pharmacogenetics in the Gendiagnostikkommission of the BMG, Germany |
| 2011-2015 | Member of the Executive Committee of the EACPT |
| since 2012 | Member of the Committee for Research Strategy & Coordination (University of Tuebingen) |
| 2012 | Full Member of the Academy of Science and Literature, Mainz, Germany |
| 2012-2015 | Chairman of the German Society of Clinical Pharmacology (DGKliPha) |
| 2013-2017 | Member in the Committee of Experts on Drug Prescription of the BMG, Germany |
| since 2013 | Member of the Board of Trustees of the European Health Foundation (EHF) |
| since 2014 | Member of the Scientific Advisory Board of the Reference Institute for Bioanalytics (Foundation for Pathobiochemistry and Molecular Diagnostics, Bonn) |
| since 2014 | Member of the German National Academy of Sciences Leopoldina |
| 2015 | President Elect of the German Society of Experimental and Clinical Pharmacology and Toxicology |
PUBLICATIONS
Peer reviewed articles: > 250
Most cited pharmacologist in German-speaking countries (Laborjournal, 2009).
Most cited German pharmacologist in Europe (LabTimes, 2013)
[/vc_column][/vc_row]